RecruitingPhase 4NCT06007222

Non-antithrombotic Therapy After Transcatheter Aortic Valve Implantation Trial

Sponsor

OCEAN-SHD Study Group

Enrollment

400 participants

Start Date

Apr 6, 2023

Study Type

INTERVENTIONAL

Conditions

Aspirin Aortic Stenosis TAVI(Transcatheter Aortic Valve Implantation)DAPT(Dual Antiplatelet Therapy)SAPT(Single Antiplatelet Therapy)

Summary

Aspirin group: Aspirin 100mg will be started within 24 hours after randomization, and continued aspirin 100mg/day the end of the study period. Non-antithrombotic group: No antithrombotic agents will be administered after randomization until the end of the study period.

Eligibility

Min Age: 20 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Aspirin group and a drug called Non-antithrombotic group for people with aortic stenosis, aspirin, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.